Abstract
Background: There are very few studies about the prevalence of allergic rhinitis in Argentina.
Objective: To determine the prevalence of allergic rhinitis in a population of inhabitants between the ages of 5 and 44 in Argentina.
Methods: A cross-sectional national study in which a self-reported questionnaire was used. The included participants are between the ages of 5 and 44 and they reside in urban areas. The information was collected by phone.
Results: 3200 participants were surveyed: 51.8% were women, 37.6% were between the ages of 5 and 19, and 62.4%, were between the ages of 20 and 44. The global prevalence of symptoms of allergic rhinitis was of 20.5%; the most frequent symptoms were sneezing (58.5%) and nasal congestion (51.4%). Overall, 44.3% of the participants had a family history of allergies. Allergic rhinitis was more frequent in women; the prevalence was of 22.3% in the group of participants between the ages of 5 and 19, and of 19.4% in the group of participants between the ages of 20 and 40 (p=0.0545); 63.8% of participants with symptoms did not have a medical diagnosis.
Conclusions: The results of this first cross-sectional national survey have confirmed the high prevalence of self-reported symptoms of allergic rhinitis in adults and children in Argentina, particularly in women.
References
Brozek JL, Bousquet J, Baena-Cagnani CE, Bonini S, Canonica GW, Casale TB, et al. Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines: 2010 revision. J Allergy Clin Immunol. 2010;126:466-476. DOI: 10.1016/j.jaci.2010.06.047
Hansel FK. Clinical and histopathologic studies of the nose and sinuses in allergy. J Allergy Clin Immunol. 1929;1(1):43-70. DOI: 10.1016/S0021-8707(29)90083-6
Linneman L, Mayrga-Butrón JL, Sánchez-González A, Ramírez-García A, Medina-Ávalos M, Figueroa-Morales MA, et al. ARIA México 2014. Adaptación de la Guía de Práctica Clínica ARIA 2010 para México. Metodología ADAPTE. Rev Alerg Mex. 2014;61(Supl 1):S3-S116. Disponible en: http://revistaalergia.mx/ojs/index.php/ram/article/view/52/94
Breinbauer H, Varela C, Núñez M, Ugarte S, Garfias R, Fonseca X. Encuesta de síntomas SNOT-20 para rinitis alérgica y rinosinusitis: validación en Chile. Rev Med Chile. 2011;139(7):886-895. DOI: 10.4067/S0034-98872011000700009
Neffen H, Mello JF, Sole D, Naspitz CK, Dodero AE, Garza HL, et al. Nasal allergies in the Latin American population: results from the Allergies in Latin America Survey. Allergy Asthma Proc. 2010;31(Suppl 1):S9-S27. DOI: 10.2500/aap.2010.31.3347
Brozek JL, Bousquet J, Agache I, Agarwal A, Bachert C, Bosnic-Anticevich S, et al. Allergic Rhinitis and its impact on Asthma (ARIA) guidelines: 2016 revision. J Allergy Clin Immunol. 2017;140(4):950-958. DOI: 10.1016/j.jaci.2017.03.050
Wheatley LM, Togias A. Clinical practice. Allergic rhinitis. N Engl J Med. 2015;372(5):456-463. DOI: 10.1056/NEJMcp1412282
Neffen HE. How can we improve management of allergic rhinitis in Latin America? Allergy Asthma Proc. 2010;31(Suppl 1):S5-S7. DOI: 10.2500/aap.2010.10.3339
Asher MI, Montefort S, Björkstén B, Lai CK, Strachan DP, Weiland SK, et al. Worldwide time trends in the prevalence of symptoms of asthma, allergic rhinoconjuntivitis, and eczema in childhood: ISAAC Phases One and Three repeat multicountry cross-sectional surveys. Lancet. 2006;368(9537):733-743. DOI: 10.1016/S0140-6736(06)69283-0
Mancilla-Hernández E, Medina-Ávalos M, Osorio-Escamilla RE. Validación de un cuestionario diagnóstico de rinitis alérgica para estudios epidemiológicos. Rev Alerg Mex. 2014;61:153-161. DOI: 10.29262/ram.v61i3.40
Mancilla-Hernández E, Medina-Ávalos M, Barnica-Alvarado RH, Soto-Candia D, Guerrero-Venegas R, Zecua-Nájera Y. Prevalence of rhinitis allergic in populations of several states of Mexico. Rev Alerg Mex. 2015;62(3):196-201. Disponible en: http://revistaalergia.mx/ojs/index.php/ram/article/view/107/208
All-Khaled N, Pearce N, Anderson HR, Ellwood P, Montefort S, Shan J, et al. Global map of the prevalence of symptoms of rhinoconjuctivitis in children: the International Study of Asthma and Allergies in Childhood (ISAAC) Phase Three. Allergy. 2009;64(1):123-148. DOI: 10.1111/j.1398-9995.2008.01884.x
Katelaris CH, Lee BW, Potter PC, Maspero JF, Cingi C, Lopatin A, et al. Prevalence and diversity of allergic rhinitis in regions of the world beyond Europe and North America. Clin Exp Allergy. 2012;42(2):186-207. DOI: 1111/j.1365-2222.2011.03891.x
Bousquet J, van Cauwenberge P, Khaltaev N, Aria Workshop Group; World Health Organization. Allergic rhinitis and its impact on asthma. J Allergy Clin Immunol. 2001;108(Suppl 1):S147:S334.
Zuberbier T, Lötvall J, Simoens S, Subramanian SV, Church MK. Economic burden of inadequate management of allergic diseases in the European Union: a GA (2) LEN review. Allergy. 2014;69(10):1275-1279
Argentina - National Population, Households, and Dwellings Census 2010. Argentina: National Institute of Statistics and Census; 2017.
Vidal Díaz-De Rada, Palacios-Gómez JL. Comparación de las tasas de respuestas en el uso combinado de modalidades de encuestas. Rev Esp Investig Soc. 2013;141:159-170.
Bauchau V, Durham SR. Prevalence and rate diagnosis of allergic rhinitis in Europe. Eur Respir J. 2004;24(5):758-764. DOI: 10.1183/09031936.04.00013904
Janson C, Anto J, Burney P, Chinn S, De Marco R, Heinrich J, et al. The European Community Respiratory Health Survey: what are the main results so far? European Community Respiratory Health Survey II. Eur Respir J. 2001;18(3):598-611. Disponible en: https://erj.ersjournals.com/content/18/3/598.long
Nathan R, Meltzer EO, Derebery J, Campbell UB, Stang PE, Corrao MA, et al. The prevalence of nasal symptoms attributed to allergies in the United States: findings from the burden of rhinitis in an America survey. Allergy Asthma Proc. 2008;29(6):600-608. DOI: 10.2500/aap.2008.29.3179
Klossek JM, Annesi-Maesano I, Pribil C, Didier A. Un tiers des adultes ont une rhinite allergique en France (enquête INSTANT). Presse Med. 2009;38(9):1220-1229. DOI: 10.1016/j.lpm.2009.05.012
Björkstén B, Clayton T, Ellwood P, Stewart A, Strachan D, ISAAC Phase Three Study Group. Worldwide time trends for symptoms of rhinitis and conjunctivitis: phase III of the International Study of Asthma and Allergies in Childhood. Pediatr Allergy Immunol. 2008;19(2):110-124. DOI: 10.1111/j.1399-3038.2007.00601.x
Pynnonen MA, Kim HM, Terrell JE. Validation of the Sino-Nasal Outcome Test 20 (SNOT-20) domains in non-surgical patients. Am J Rhinol Allergy. 2009;23(1):40-45. DOI: 10.2500/ajra.2009.23.3259
Nogueira-Silva L, Martins SV, Cruz-Correia R, Azevedo LF, Morais-Almeida M, Bugalho-Almeida A, et al. Control of allergic rhinitis and asthma test formal approach to the development of a measuring tool. Respir Res. 2009;10:52. DOI: 10.1186/1465-9921-10-52
Kim H, Levin L, LeMasters GK, Villareal M, Evans S, Lockey JE, et al. Validating childhood symptom with physician diagnosed allergic rhinitis. Ann Allergy Asthma Immunol. 2012;108(4):228-231. DOI: 10.1016/j.anai.2012.02.004
Del Río-Navarro B, Luna-Pech JA, Berber A, Zepeda-Ortega B, Ávila-Castañón L, Del Río Chivardi JM, et al. Factors associated with allergic rhinitis in children from northern Mexico city. J Investig Clin Immunol. 2007;17(2):77-84. Disponible en: http://www.jiaci.org/issues/vol17issue02/3.pdf

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Copyright (c) 2019 Revista Alergia México